【艾美疫苗(06660.HK):全面接入DeepSeek大模型 实现“AI+疫苗智慧企业”战略升级】艾美疫苗(06660.HK)发布公告,作为中国头部的疫苗企业,集团积极响应国家“AI+”产业发展战略,全面部署接入DeepSeek大模型,通过本地化策略,推动DeepSeek R1版本在集团全业务场景应用,实现疫苗全生命周期的“降本、提质、增效”。

金融界
23 Feb
艾美疫苗(06660.HK)发布公告,作为中国头部的疫苗企业,集团积极响应国家“AI+”产业发展战略,全面部署接入DeepSeek大模型,通过本地化策略,推动DeepSeek R1版本在集团全业务场景应用,实现疫苗全生命周期的“降本、提质、增效”。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10